Podcast Q&A: Cell & Gene Therapies
In this episode of tHEORetically Speaking, join Dr. Pamela Landsman-Blumberg, Amanda O’Hora, and Ajay Keshava from Magnolia Market Access, who answer questions from a recent webinar on how early stage planning taking into account commercial production, logistics, reimbursement, and health inequities can lead to successful approvals and market adoption.
Cell & Gene Therapies – Beginning with the End in Mind
This webinar discusses how early stage planning taking into account commercial production, logistics, reimbursement, and health inequities can lead to successful approvals and market adoption.
Podcast Q&A: HEOR for Medical Technologies for the US Healthcare System
Expert, Deepak Sahu answers questions on developing HEOR studies for generating short- and long-term effectiveness data for medical technology.